FUT2 Secretor Status Influences Susceptibility to VP4 Strain-Specific Rotavirus Infections in South African Children
- PMID: 32992488
- PMCID: PMC7601103
- DOI: 10.3390/pathogens9100795
FUT2 Secretor Status Influences Susceptibility to VP4 Strain-Specific Rotavirus Infections in South African Children
Abstract
Gastroenteritis is a preventable cause of morbidity and mortality worldwide. Rotavirus vaccination has significantly reduced the disease burden, but the sub-optimal vaccine efficacy observed in low-income regions needs improvement. Rotavirus VP4 'spike' proteins interact with FUT2-defined, human histo-blood group antigens on mucosal surfaces, potentially influencing strain circulation and the efficacy of P[8]-based rotavirus vaccines. Secretor status was investigated in 500 children <5 years-old hospitalised with diarrhoea, including 250 previously genotyped rotavirus-positive cases (P[8] = 124, P[4] = 86, and P[6] = 40), and 250 rotavirus-negative controls. Secretor status genotyping detected the globally prevalent G428A single nucleotide polymorphism (SNP) and was confirmed by Sanger sequencing in 10% of participants. The proportions of secretors in rotavirus-positive cases (74%) were significantly higher than in the rotavirus-negative controls (58%; p < 0.001). The rotavirus genotypes P[8] and P[4] were observed at significantly higher proportions in secretors (78%) than in non-secretors (22%), contrasting with P[6] genotypes with similar proportions amongst secretors (53%) and non-secretors (47%; p = 0.001). This suggests that rotavirus interacts with secretors and non-secretors in a VP4 strain-specific manner; thus, secretor status may partially influence rotavirus VP4 wild-type circulation and P[8] rotavirus vaccine efficacy. The study detected a mutation (rs1800025) ~50 bp downstream of the G428A SNP that would overestimate non-secretors in African populations when using the TaqMan® SNP Genotyping Assay.
Keywords: FUT2; VP4 genotypes; histo-blood group antigens; rotavirus; secretor status; susceptibility; vaccines.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures

Similar articles
-
Non-Secretor Status Due to FUT2 Stop Mutation Is Associated with Reduced Rotavirus Infections but Not with Other Enteric Pathogens in Rwandan Children.Microorganisms. 2025 May 3;13(5):1071. doi: 10.3390/microorganisms13051071. Microorganisms. 2025. PMID: 40431244 Free PMC article.
-
Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.J Infect Dis. 2020 Mar 16;221(7):1070-1078. doi: 10.1093/infdis/jiz333. J Infect Dis. 2020. PMID: 31763671 Free PMC article.
-
Association of elevated rotavirus-specific antibody titers with HBGA secretor status in Swedish individuals: The FUT2 gene as a putative susceptibility determinant for infection.Virus Res. 2016 Jan 4;211:64-8. doi: 10.1016/j.virusres.2015.10.005. Epub 2015 Oct 26. Virus Res. 2016. PMID: 26454189
-
Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.Viruses. 2021 Jun 14;13(6):1144. doi: 10.3390/v13061144. Viruses. 2021. PMID: 34198720 Free PMC article. Review.
-
Influence of histo blood group antigen expression on susceptibility to enteric viruses and vaccines.Curr Opin Infect Dis. 2019 Oct;32(5):445-452. doi: 10.1097/QCO.0000000000000571. Curr Opin Infect Dis. 2019. PMID: 31335438 Review.
Cited by
-
ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies.iScience. 2022 Dec 14;26(1):105798. doi: 10.1016/j.isci.2022.105798. eCollection 2023 Jan 20. iScience. 2022. PMID: 36691627 Free PMC article. Review.
-
Global Experience With Rotavirus Vaccines.J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S792-S800. doi: 10.1093/infdis/jiab399. J Infect Dis. 2021. PMID: 34374426 Free PMC article.
-
Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.J Infect Dis. 2024 Apr 12;229(4):1010-1018. doi: 10.1093/infdis/jiad351. J Infect Dis. 2024. PMID: 37592804 Free PMC article.
-
Rotaviruses and Rotavirus Vaccines.Pathogens. 2021 Jul 29;10(8):959. doi: 10.3390/pathogens10080959. Pathogens. 2021. PMID: 34451423 Free PMC article.
-
Non-Secretor Status Due to FUT2 Stop Mutation Is Associated with Reduced Rotavirus Infections but Not with Other Enteric Pathogens in Rwandan Children.Microorganisms. 2025 May 3;13(5):1071. doi: 10.3390/microorganisms13051071. Microorganisms. 2025. PMID: 40431244 Free PMC article.
References
-
- Troeger C., Forouzanfar M., Rao P.C., Khalil I., Brown A., Reiner R.C., Fullman N., Thompson R.L., Abajobir A., Ahmed M., et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 2017;17:909–948. doi: 10.1016/S1473-3099(17)30276-1. - DOI - PMC - PubMed
-
- Troeger C., Khalil I.A., Rao P.C., Cao S., Blacker B.F., Ahmed T., Armah G., Bines J.E., Brewer T.G., Colombara D.V., et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–965. doi: 10.1001/jamapediatrics.2018.1960. - DOI - PMC - PubMed
-
- Steele A.D., Victor J.C., Carey M.E., Tate J.E., Atherly D.E., Pecenka C., Diaz Z., Parashar U.D., Kirkwood C.D. Experiences with rotavirus vaccines: Can we improve rotavirus vaccine impact in developing countries? Hum. Vaccin. Immunother. 2019;15:1215–1227. doi: 10.1080/21645515.2018.1553593. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources